Business Context and Reporting Period
Company: DaVita HealthCare Partners Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 10, 2014
Event: Entry into an Underwriting Agreement for a public offering of senior notes.
Key Financial Metrics
This filing reports a specific capital raising event rather than periodic financial performance metrics (revenue, profit, cash flow, or margins).
- Debt Issuance: $1,750,000,000 aggregate principal amount.
- Instrument: 5.125% Senior Notes due 2024.
- Underwriters: Wells Fargo Securities, LLC and Barclays Capital Inc. (as representatives).
- Liquidity Impact: Proceeds expected upon closing to increase cash reserves, subject to customary closing conditions.
Material Changes
The filing discloses a material change in the Company's capital structure through the planned issuance of long-term debt. No comparative financial data or changes in operating metrics versus prior periods are provided in this document.
Guidance, Outlook, and Risks
Outlook and Closing: The offering is expected to close on June 13, 2014, subject to the satisfaction of customary closing conditions.
Regulatory Context: The offering is conducted pursuant to an effective shelf registration statement on Form S-3 (File No. 333-196630).
Risks and Contingencies: The transaction is contingent upon customary closing conditions. The Underwriting Agreement contains standard representations, warranties, indemnification rights, and termination provisions. The filing text does not provide specific details on unusual items or forward-looking guidance beyond the closing date.
Investor Verification Checklist
- Verify the final closing date of the offering (expected June 13, 2014).
- Confirm the use of proceeds from the $1.75 billion note issuance in subsequent filings.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and termination rights.
- Monitor the Company's debt-to-equity ratio following the addition of $1.75 billion in senior debt.